Assignee
KNOPP BIOSCIENCES LLC
US·28 granted patents·5 pending applications·127 citations·filing 2012–2022
Top patents by PatentIndex Score
33 records- 0196US11724990B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2022·Granted Aug 15, 2023·4 cites·14 claims
- 0296US11261162B2KV7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2020·Granted Mar 1, 2022·3 cites·20 claims
- 0395US10851067B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2019·Granted Dec 1, 2020·6 cites·28 claims
- 0495US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0594US9642840B2Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disordersKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 9, 2017·10 cites·16 claims
- 0694US9468630B2Compositions and methods for treating conditions related to increased eosinophilsKNOPP BIOSCIENCES LLC·Filed 2013·Granted Oct 18, 2016·14 cites·25 claims
- 0793US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 0892US10385025B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·9 cites·16 claims
- 0992US10106536B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2017·Granted Oct 23, 2018·5 cites·12 claims
- 1091US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1189US11026928B2Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jun 8, 2021·3 cites·40 claims
- 1289US9956206B2Compositions and methods for treating amyotrophic lateral sclerosis in respondersKNOPP BIOSCIENCES LLC·Filed 2017·Granted May 1, 2018·4 cites·22 claims
- 1388US10980783B2Compositions and methods for treating conditions related to increased eosinophilsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Apr 20, 2021·2 cites·26 claims
- 1488US9763918B2Compositions and methods for treating chronic urticariaKNOPP BIOSCIENCES LLC·Filed 2014·Granted Sep 19, 2017·4 cites·64 claims
- 1587US9662313B2Compositions and methods for treating amyotrophic lateral sclerosis in respondersKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 30, 2017·6 cites·25 claims
- 1686US10383856B2Compositions and methods for treating conditions related to increased eosinophilsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Aug 20, 2019·2 cites·24 claims
- 1786US10179774B2Synthesis of chirally purified substituted benzothiazole diaminesKNOPP BIOSCIENCES LLC·Filed 2016·Granted Jan 15, 2019·3 cites·36 claims
- 1884US10906877B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Feb 2, 2021·1 cites·8 claims
- 1984US10028940B2Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disordersKNOPP BIOSCIENCES LLC·Filed 2017·Granted Jul 24, 2018·3 cites·28 claims
- 2083US10383857B2Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·2 cites·55 claims
- 2183US10208003B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Feb 19, 2019·3 cites·65 claims
- 2283US10195183B2Compositions and methods for treating chronic urticariaKNOPP BIOSCIENCES LLC·Filed 2017·Granted Feb 5, 2019·3 cites·22 claims
- 2383US9849116B2Compositions and methods of using (R)-pramipexoleKNOPP BIOSCIENCES LLC·Filed 2015·Granted Dec 26, 2017·3 cites·14 claims
- 2482US9512096B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2012·Granted Dec 6, 2016·3 cites·53 claims
- 2576US10828284B2Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsKNOPP BIOSCIENCES LLC·Filed 2014·Granted Nov 10, 2020·1 cites·34 claims
- 2674US2022040154A1Use of dexpramipexole for the treatment of moderate to severe asthmaKNOPP BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 2770US10456381B2Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disordersKNOPP BIOSCIENCES LLC·Filed 2018·Granted Oct 29, 2019·0 cites·36 claims
- 2868US10526328B2Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jan 7, 2020·0 cites·1 claims
- 2966US10285981B2Compositions and methods for treating amyotrophic lateral sclerosis in respondersKNOPP BIOSCIENCES LLC·Filed 2018·Granted May 14, 2019·0 cites·21 claims
- 3064US2020155516A1Compositions and methods of using (r)-pramipexoleKNOPP BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 3155US2018110758A1Compositions and methods of using (r)-pramipexoleKNOPP BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
- 3254US2016022647A1Compositions and methods of using r(+) pramipexoleKNOPP BIOSCIENCES LLC·Filed 2015·Application pending·0 cites
- 3340US2020062714A1BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSKNOPP BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KNOPP BIOSCIENCES LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →